Navigation Links
Medical Marijuana, Inc. Announces First Quarter 2012 Results
Date:5/15/2012

SAN DIEGO, May 15, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), one of the medical marijuana (MMJ) industry's premier cannabis and hemp industry innovators, today announced its first quarter earnings.  The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012.  This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.

Operational and development highlightsOperating highlights of the quarter were as follows:

  • Acquired two additional Wellness Managed Services accounts which will generate estimated annual revenues of $1.7 million.
  • Closed a $1.04 million upfront payment licensing transaction for high value hemp extracts.
  • Retired 14,600,000 shares worth approximately $1.0 million dollars.
  • Cannabank, the private equity group that finances and incubates early stage acquisitions for MJNA, has agreed to finance several key transactions for the company including the European based pharmaceutical firm previously announced.
  • Secured $4 million in non-dilution, non-recourse finance for the acquisition and development of strategic acquisitions. 
  • In addition, since the close of the first quarter, Medical Marijuana, Inc. has:

  • Completed the acquisition of Dixie Elixirs & Edibles brand, intellectual property, proprietary formulas and extraction processes. In conjunction it formed Red Dice Holdings, as was announced in late April, to develop manufacturing and distribution partnerships for Dixie in every state and country that has legalized medical cannabis.
  • Begun hemp-based extraction product development beyond the medical marijuana industry, crossing into the nationally legal category of health and wellness with such products as sleep aids, topical and pain management. A market launch of the new products is expected by the end of the second quarter.
  • Brought PhytoSPHERE systems on-line and will begin to market the benefits of its seed-to-sale product growth and cultivation technology in an attempt to secure licensing agreements worldwide.
  • Comments regarding operations and outlook"The first quarter of 2012 brought into clear focus all that we have been working towards since Cannabank's initial investment into Medical Marijuana, Inc. about a year ago," said Michael Llamas, President of Medical Marijuana, Inc. "We have spent this last year essentially getting our house in order by clarifying the growth strategy and systematically identifying, acquiring and growing early stage companies across the spectrum of the MMJ industry from product development to retail sales.  As witnessed by our strong quarter-over-quarter and year-over-year growth, there is tremendous opportunity in this industry.  We have the capital and the systems in place to buy, incubate and grow the best companies across multiple categories within the industry. At the same time, there is aggressive natural attrition of other companies and whole categories as the industry right sizes itself-which creates further opportunities and differentiation for Medical Marijuana, Inc. this truly is the perfect storm for acquiring income producing businesses.

    "However, we also know that a 12,000 percent year-over-year growth is decidedly a factor of where we are in our growth cycle. We won't always have such favorable comparables moving forward past our second year. We do expect the comparable growth to normalize, but more importantly, we expect continued healthy growth in our core businesses as they begin to mature and the industry stabilizes. I'm equally proud that we have been able to maintain this rapid growth with a small core of dedicated and truly innovative employees and as a result, our operating costs have begun to stabilize since the close of the fourth quarter. We anticipate continued cost efficiency in line with future growth."

    Additional operational updates for 2012

  • The Company has built additional raw ingredients supply sources on four continents in preparation for international expansion and it continues to develop international sales and distribution channels for its high-value extracts and compounds and related products produced by Dixie Elixirs and Edibles.
  • Medical Marijuana, Inc.'s Wellness Managed Services (WMS) division plans to expand internationally to provide additional clinics, doctor's offices and wellness centers under the WMS umbrella.
  • PhytoSPHERE plans to develop and launch a national/international marketing campaign in the third quarter to support sales of licensing agreements for its proprietary indoor planting, cultivation and extraction technology.
  • Medical Marijuana, Inc. plans to establish a "Raw Ingredients Division" by the third quarter to provide raw ingredients and production services to other cannabis-based businesses.
  • MJNA to begin regular Investor Conference Calls announcing quarterly results and/or upon significant corporate developments beginning with its second quarter results (date is currently TBD).
  • MJNA established a corporate website and launched a rebranding effort for added market and shareholder awareness.
  • The Company is aggressively pursuing the acquisition and filing of additional product patents. 
  • "With 16 states and Washington, D.C. allowing for legal use of medical marijuana and twelve more states with legalization initiatives on the ballot, we are confident that the opportunity for continued growth in the US, regardless of state boundaries, is exceptional," added Llamas. "Equally as important is the growing movement towards decriminalization outside the US and across Europe, which will allow us to leverage what we have learned in mature legalized states like Colorado and California, and apply it to international markets. We see opportunity for significant national and international expansion by the end of 2012 and we are currently putting in place the necessary supply chain and infrastructure elements to best position Medical Marijuana, Inc. and our shareholders to benefit from this growth."

    Financial TablesThree months ended Mar. 31, 2011Three months ended Jun. 30, 2011Three months ended Sept. 30, 2011Three months ended Dec. 31, 2011Three months ended Mar. 31, 2012Revenue$20,426

    $196,748

    $198,813

    $430,140

    $1,788,445Assets$74,376

    $568,116

    $1,443,251

    $1,948,165

    $6,356,301Debt$73,403

    $103,464

    $14,879

    $26,785

    $101,778Net Income($42,613)

    ($1,292,722)

    ($1,067,473)

    ($62,711)

    $1,208,136FORWARD-LOOKING DISCLAIMER

    This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections.  This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

    About Medical Marijuana, Inc.Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit.  We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.  For more information, please visit the company's website at:  www.MedicalMarijuanaInc.com.

    Corporate Contact:
    Medical Marijuana, Inc.
    Toll Free:  888-OTC-MJNA (888-682-6562)
    www.medicalmarijuanainc.com
    www.facebook.com/mjnainc

    Investor Relations Contact:
    Stuart T. Smith
    SmallCapVoice.Com, Inc.
    P. 512-267-2430
    F. 512-267-2530
    Skype: SmallCapVoice.com
    AIM: SmallCapVoice7


    '/>"/>

    SOURCE Medical Marijuana, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. BiO2 Medical Granted CE Mark for the Angel™ Catheter, the First IVC Filter with a Prophylactic Use Indication
    2. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
    3. Medicalbillersandcoders.com the Market Leader in Placing Certified Medical Coders in New Mexico
    4. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
    5. Neusoft Medical Launches NeuViz 64 Multi-slice CT Scanner at CMEF Spring 2012
    6. Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows
    7. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
    8. Flexpoint Receives Purchase Order for Medical Device Used in Procedure Performed Millions of Times Annually
    9. Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
    10. Millstone Medical Outsourcing Hires New Vice President Quality
    11. WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
    (Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
    (Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
    Breaking Medicine Technology:
    (Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
    (Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
    (Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
    (Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
    (Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
    Breaking Medicine News(10 mins):